Tower Research Capital LLC TRC boosted its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 1,178.4% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,720 shares of the company’s stock after buying an additional 3,429 shares during the period. Tower Research Capital LLC TRC’s holdings in Thermo Fisher Scientific were worth $549,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in the stock. Emerald Acquisition Ltd. purchased a new position in shares of Thermo Fisher Scientific during the second quarter valued at about $200,618,000. Wellington Management Group LLP increased its position in shares of Thermo Fisher Scientific by 26.0% in the first quarter. Wellington Management Group LLP now owns 6,135,669 shares of the company’s stock valued at $868,749,000 after buying an additional 1,267,967 shares in the last quarter. Sound Shore Management Inc. CT increased its position in shares of Thermo Fisher Scientific by 123.5% in the second quarter. Sound Shore Management Inc. CT now owns 2,204,253 shares of the company’s stock valued at $138,096,000 after buying an additional 1,217,950 shares in the last quarter. JPMorgan Chase & Co. increased its position in shares of Thermo Fisher Scientific by 72.3% in the first quarter. JPMorgan Chase & Co. now owns 1,953,935 shares of the company’s stock valued at $276,658,000 after buying an additional 820,110 shares in the last quarter. Finally, Carmignac Gestion increased its position in shares of Thermo Fisher Scientific by 23.3% in the second quarter. Carmignac Gestion now owns 4,046,550 shares of the company’s stock valued at $597,918,000 after buying an additional 763,421 shares in the last quarter. 87.47% of the stock is owned by hedge funds and other institutional investors.

Thermo Fisher Scientific Inc. (NYSE:TMO) opened at 150.05 on Monday. The firm has a market cap of $59.16 billion, a PE ratio of 30.02 and a beta of 1.00. The stock has a 50 day moving average of $153.94 and a 200 day moving average of $148.48. Thermo Fisher Scientific Inc. has a 12-month low of $117.10 and a 12-month high of $160.68.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings data on Thursday, July 28th. The company reported $2.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.01 by $0.02. The business earned $4.54 billion during the quarter, compared to analyst estimates of $4.50 billion. Thermo Fisher Scientific had a net margin of 11.35% and a return on equity of 14.70%. The firm’s quarterly revenue was up 6.2% on a year-over-year basis. During the same quarter last year, the business earned $1.84 EPS. On average, equities research analysts anticipate that Thermo Fisher Scientific Inc. will post $8.15 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, October 17th. Investors of record on Thursday, September 15th will be issued a $0.15 dividend. The ex-dividend date of this dividend is Tuesday, September 13th. This represents a $0.60 dividend on an annualized basis and a yield of 0.40%. Thermo Fisher Scientific’s dividend payout ratio (DPR) is presently 12.02%.

A number of brokerages have weighed in on TMO. Zacks Investment Research raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $175.00 target price for the company in a research note on Wednesday, July 20th. BTIG Research raised shares of Thermo Fisher Scientific from a “neutral” rating to a “buy” rating and set a $180.00 target price for the company in a research note on Friday, July 22nd. Mizuho set a $175.00 target price on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a research note on Thursday, July 28th. Cleveland Research downgraded shares of Thermo Fisher Scientific from a “buy” rating to a “neutral” rating in a research note on Friday, September 9th. Finally, Jefferies Group reaffirmed a “hold” rating on shares of Thermo Fisher Scientific in a research note on Thursday, August 4th. Three investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $159.66.

In related news, CEO Marc N. Casper sold 28,797 shares of the firm’s stock in a transaction that occurred on Friday, September 2nd. The shares were sold at an average price of $151.01, for a total value of $4,348,634.97. Following the completion of the transaction, the chief executive officer now owns 307,444 shares in the company, valued at approximately $46,427,118.44. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Marc N. Casper sold 20,000 shares of the firm’s stock in a transaction that occurred on Tuesday, July 5th. The shares were sold at an average price of $147.69, for a total transaction of $2,953,800.00. Following the completion of the transaction, the chief executive officer now owns 340,998 shares of the company’s stock, valued at approximately $50,361,994.62. The disclosure for this sale can be found here. 0.52% of the stock is currently owned by corporate insiders.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

5 Day Chart for NYSE:TMO

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Receive News & Ratings for Thermo Fisher Scientific Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.